Esophageal Squamous Cell Carcinoma — Trials

Esophageal Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

555 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 212
Recruiting: 119
Ph III recruiting: 20
Growth YoY: +61.4%
Industry share: 23%
Top sponsor: Fudan University
Termination share: 25%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (35)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07312578	Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma	enrolling by invitation	Phase 2	48	Peking UniversityOTHER	1	Dec 31, 2025	clinicaltrials
NCT06303583	Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma(CRIS)	enrolling by invitation	Phase 1 / Phase 2	30	Qiu GuoqinOTHER	1	Mar 12, 2024